COVID vaccines for children ages 5 and under – the final age group to be able to access a vaccine – have been endorsed by the US Food and Drug Administration and are expected to be available to children in Utah starting next week.
The FDA this week reviewed scientific evidence submitted for vaccines by Moderna, for children ages 6 months to 5 years, and Pfizer-BioNTech, for children ages 6 months to 4 years. The advisory panel of outside experts unanimously voted for approval of both vaccine for this age group 21-0.
What do parents need to know about the COVID-19 vaccine for young children? What are the benefits? What are potential side effects –or things to watch out for? How might getting the vaccine affect a child’s regular vaccination schedule?
Andrew Pavia, MD, chief of pediatric infectious diseases at the University of Utah and director of epidemiology at Intermountain Primary Children’s Hospital, will address these and other questions as part of an Intermountain Healthcare Community COVID Update on Friday, June 17, at noon, MT.
The update also will be broadcast live on Facebook.
Noon, MT, Friday June 17, 2022
Dr. Andrew Pavia
University of Utah Health and Intermountain Primary Children’s Hospital
Intermountain Facebook Page and Zoom Press Briefing